You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Type 2 Inflammation
EAACI 2023 | Pediatric Type 2 Inflammatory Disease Progression
Dr. Leonard Bacharier and Profs. Oscar Palomares and Stephan Weidinger explore shared features of type 2 pathophysiology in AD, asthma, and EoE, and disease burden in pediatric patients
PhD
Oscar Palomares +2 more
Learning objectives
- Evaluate the key and central role of IL-4 and IL-13 in local and systemic effects of disease pathology and the role of IL-4 in driving type 2 amplification and chronicity of disease progression
- Understand the importance of understanding potential disease trajectories in pediatric patients and the onset and persistence of type 2 inflammation
Description
Join global experts Oscar Palomares, PhD; Stephan Weidinger, MD, PhD; and Leonard Bacharier, MD, as they explore shared and distinct elements of underlying type 2 pathophysiology in atopic dermatitis (AD), asthma, and eosinophilic esophagitis (EoE), and the impact on disease burden in pediatric patients.
Tags
MAT-GLB-2302311 v2.0 06/2023
About these experts
Related resources
